Aculeus Therapeutics Overview
- Headquarters
- Vic, Au
- Industry
- Biotechnology
- Employees
- 8
- Founded
- 2020
About Aculeus Therapeutics
Aculeus Therapeutics is a Biotech company based in Melbourne Australia, developing small molecule drugs that modulate the immune system for the treatment of cancer and other serious diseases. Aculeus is doing this by developing drugs that target the Stimulator of Interferon Genes (STING) biochemical pathway. Aculeus in-licensed its lead programs, STING and ENPP1, in 2020 from the CRC for Cancer Therapeutics, a Public Private Partnership between a number of Australia’s leading Medical Research Institutes, Universities and Industry partners with a track record of scientific and commercial success.
Aculeus Therapeutics Contact Details
- People in AeroLeads
- 3
- With contact data
- 1
- Email contacts
- 1
- 33.3% coverage
Aculeus Therapeutics Org Chart
Sample employees and titles| Name | Title | Location | Contact |
|---|---|---|---|
| Grant Pestell | Managing Director at Mph Lawyers | Greater Perth Area, Australia |
Email
|
| Mark Devlin | Chief Executive Officer at Aculeus | Greater Melbourne Area, Australia |
View
|
| Benjamin Morrow | Head of Chemistry @ Aculeus | Greater Melbourne Area, Australia |
View
|
Employees by Management Level
Executive
1 profile
VP / Head
1 profile
Director
1 profile
Compare Similar Companies to Aculeus Therapeutics
Ipsen
Pharmaceutical Manufacturing
BioCina
Pharmaceutical Manufacturing
Agilex Biolabs Pty Ltd
Biotechnology
Cell Therapies Pty Ltd
Biotechnology Research
Imugene Limited
Biotechnology Research
Amplia Therapeutics Limited
Pharmaceutical Manufacturing
Anaxis Pharma
Biotechnology Research
Canthera Discovery (Canthera Discovery Ltd)
Biotechnology
SYNthesis Research
Biotechnology Research
Oncology One Pty Ltd
Biotechnology Research